Skip to content
Global sound
Microdosing

Microdosing

The Next Safety Gap; How Compounded GLP-1s Expose the Limits of Oversight

· 8 min

Show notes

As demand for GLP-1 drugs like Ozempic and Wegovy soars, a parallel market for compounded versions has emerged — one that’s largely unregulated and increasingly risky. This episode examines how gaps in oversight, aggressive marketing, and blurred lines between compounding and manufacturing expose patients to safety concerns and strain the health system. We explore why compounded GLP-1s are more than a niche issue, highlighting how they fit a recurring pattern where regulation lags behind fast-moving markets.

Website: podcasters.spotify.com

Live, last hour: 9,768 songs on 4,161 stations in 130 countries

Discover the world through radio

More ways to discover (7)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Rockabilly - Caprice RadioContinue listening